Role for Afatinib in p16-Negative Head and Neck Cancer?
This video reviews results of LUX-Head & Neck 2, a randomized phase III trial that studied afatinib as adjuvant therapy in patients with unresected squamous cell head and neck cancer.
Bevacizumab Improves Responses, PFS in Advanced Head and Neck Cancer
This video highlights results of a phase III randomized trial that tested chemotherapy plus bevacizumab in patients with recurrent or metastatic head and neck cancer.
HPV Vaccination Reduced Oral HPV Infections
Prophylactic HPV vaccination significantly reduced vaccine-type oral HPV infections among young adults, according to the results of a cross-sectional study.
Head and Neck Cancer Patients Need Coordinated Survivorship Care Planning
Improving oropharyngeal cancer survival rates necessitates better coordination of survivorship care between oncology teams and primary care providers, according to a presentation at ONS.
New ASTRO Guidelines for Oropharyngeal Cancer
In this interview we discuss new clinical guidelines from ASTRO on the use of radiotherapy in treating oropharyngeal cancer.
Surgery Plus RT Improves Survival Over Chemo Plus RT in Oral Cavity Carcinoma
Surgery followed by postoperative radiotherapy was associated with prolonged overall survival compared with concurrent chemoradiotherapy in patients with locally advanced oral cavity squamous cell carcinoma.
Survival Worse in Patients With Rare Oropharyngeal Small-Cell Carcinoma
Oropharyngeal small-cell carcinoma was more likely to present as distant disease and was associated with worse survival outcomes compared with squamous cell carcinoma, according to new research.
Immunotherapy Trials in Head and Neck Cancer
This video reviews ongoing trials testing immunotherapy for patients with head and neck cancer.
Reducing Treatment Doses in Head and Neck Cancer to Improve QOL
In this video we discuss efforts to reduce treatment doses in order to lessen long-term side effects and improve quality of life among patients with head and neck cancers.
By clicking Accept, you agree to become a member of the UBM Medica Community.